While clinical factors are not suitable to determine sensitivity to PD-1 inhibition and PD-L1 expression does not predict response in squamous-NSCLC, the SQ-cytoscore may serve as a predictive marker for anti-PD-1 therapy. Here, CD274 is linked to non-small cell lung carcinoma.